Researchers at Stanford have developed a novel cell-free stem cell derived extracellular vesicle (EV) therapy powered by pulsed focused ultrasound (pFUS) that enhances its therapeutic and bioenergetic effect.
Stanford scientists have invented a new suite of adaptable hydrogel biomaterials that are optically transparent and injectable for cell encapsulation, tissue engineering, and drug delivery.
Stanford researchers have designed a new 3-dimensional (3D) hydrogel cell culture system that models native tissue environment with precise control over gelation and degradation properties.
Stanford researchers at the Snyder Lab have developed a method for simultaneously measuring thousands of proteins, lipids, and metabolites from home-collected 10 ?L blood samples in conjunction with wearable sensors.
Stanford researchers from the Khuri-Yakub group have designed an improved, high spatial resolution ultrasonic neuromodulation device that implements chip waveform instead of continuous wave PIRF.
Stanford researchers have patented methods to improve phagocytosis, the process by which macrophages clear protein aggregates, dying cells, and debris, to treat age-related diseases.
The blood-brain barrier is a huge challenge when it comes to the delivery of therapeutic proteins to treat genetic diseases, injury, and neurodegenerative diseases.
Dr. Maheen Mausoof Adamson and colleagues have developed a personalized non-verbal communication device and associated app for post-stroke expressive aphasia patients.
Using advances in flexible electronics, researchers at Stanford have developed a stretchable strain sensor for monitoring solid tumor size progression on or near the skin in real time.